[Federal Register: May 7, 2009 (Volume 74, Number 87)]
[Notices]
[Page 21355-21356]
[DOCID:fr07my09-50]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP05-82-001]

El Paso Natural Gas Company; Notice of Petition To Amend

April 30, 2009.
    Take notice that on March 20, 2009, El Paso Natural Gas Company (El
Paso), P.O. Box 1087, Colorado Springs, Colorado 80944, filed a
petition to amend the order issued May 5, 2005, in Docket Number CP05-
82-000, pursuant to Rules 207 and 2001, et seq., of the Commission's
Rules of Practice and Procedure. Specifically, El Paso seeks amended
authorization to remove all previously abandoned aboveground facilities
at its Gila Compressor Station, all as more fully set forth in the
application which is on file with the Commission and open to public
inspection. The filing may also be viewed on the Web at http://
www.ferc.gov using the ``eLibrary'' link. Enter the docket number
excluding the last three digits in the docket number field to access
the document. For assistance, call<PHONE_NUMBER> or TYY, (202) 502-
8659.
    Any questions regarding the petition should be directed to Richard

Derryberry, Director, Regulatory Affairs, El Paso Natural Gas Company,
P.O. Box 1087, Colorado Springs, Colorado 80944, phone<PHONE_NUMBER>
or fax<PHONE_NUMBER>.
    Pursuant to section 157.9 of the Commission's rules, 18 CFR 157.9,
within 90 days of this Notice the Commission staff will either:
Complete its environmental assessment (EA) and place it into the
Commission's public record (eLibrary) for this proceeding, or issue a
Notice of Schedule for Environmental Review. If a Notice of Schedule
for Environmental Review is issued, it will indicate, among other
milestones, the anticipated date for the Commission staff's issuance of
the final environmental impact statement (FEIS) or EA for this
proposal. The filing of the EA in the Commission's public record for
this proceeding or the issuance of a Notice of Schedule for
Environmental Review will serve to notify Federal and State agencies of
the timing for the completion of all necessary reviews, and the
subsequent need to complete all Federal authorizations within 90 days
of the date of issuance of the Commission staff's FEIS or EA.
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the below listed comment date, file with the Federal Energy
Regulatory Commission, 888 First Street, NE, Washington, DC 20426, a
motion to intervene in accordance with the requirements of the
Commission's Rules of Practice and Procedure (18 CFR 385.214 or
385.211) and the Regulations under the NGA (18 CFR 157.10). A person
obtaining party status will be placed on the service list maintained by
the Secretary of the Commission and will receive copies of all
documents filed by the applicant and by all other parties. A party must
submit 14 copies of filings made with the Commission and must mail a
copy to the applicant and to every other party in the proceeding. Only
parties to the proceeding can ask for court review of Commission orders
in the proceeding.
    However, a person does not have to intervene in order to have
comments considered. The second way to participate is by filing with
the Secretary of the Commission, as soon as possible, an original and
two copies of comments in support of or in opposition to this project.
The Commission will consider these comments in determining the
appropriate action to be taken, but the filing of a comment alone will
not serve to make the filer a party to the proceeding. The Commission's
rules require that persons filing comments in opposition to the project
provide copies of their protests only to the party or parties directly
involved in the protest.
    Persons who wish to comment only on the environmental review of
this project should submit an original and two copies of their comments
to the Secretary of the Commission. Environmental commenters will be
placed on the Commission's environmental mailing list, will receive
copies of the environmental documents, and will be notified of meetings
associated with the Commission's environmental review process.
Environmental commenters will not be required to serve copies of filed
documents on all other parties. However, the non-party commenters will
not receive copies of all documents filed by other parties or issued by
the Commission (except for the mailing of environmental documents
issued by the Commission) and will not have the right to seek court
review of the Commission's final order.
    Motions to intervene, protests and comments may be filed
electronically via the Internet in lieu of paper; see, 18 CFR
385.2001(a)(1)(iii) and the instructions on the Commission's Web site
under the ``e-Filing'' link. The Commission strongly encourages
electronic filings.
    Comment Date: May 21, 2009.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-10519 Filed 5-6-09; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Pages 49568-49569]
[FR Doc No: 2018-21404]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID: FEMA-2018-0022; OMB No. 1660-0059]

Agency Information Collection Activities: Submission for OMB
Review; Comment Request; National Flood Insurance Program Call Center
and Agent Referral Enrollment Form

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA) will submit the
information collection abstracted below to the Office of Management and
Budget for review and clearance in accordance with the requirements of
the Paperwork Reduction Act of 1995. The submission will describe the
nature of the information collection, the categories of respondents,
the estimated burden (i.e., the time, effort and resources used by
respondents to respond) and cost, and the actual data collection
instruments FEMA will use.

DATES: Comments must be submitted on or before November 1, 2018.

ADDRESSES: Submit written comments on the proposed information
collection to the Office of Information and Regulatory Affairs, Office
of Management and Budget. Comments should be addressed to the Desk
Officer for the Department of Homeland Security, Federal Emergency
Management Agency, and sent via electronic mail to
[email protected].

FOR FURTHER INFORMATION CONTACT: Requests for additional information or
copies of the information collection should be made to Director,
Information Management Division, 500 C Street SW, Washington, DC 20472,
email address [email protected] or
Susan Bernstein, Insurance Specialist, FIMA, Marketing and Outreach
Branch,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: This proposed information collection
previously published in the Federal Register on June 15, 2018 at 83 FR
28007 with a 60-day public comment period. FEMA received one public
comment that did not require any adjudication related to the
information collection. Under Flood Disaster Protection Act of 1973,
Section 2(a)(6), 42 U.S.C. 4002(a)(6), Congress finds it is in the
public interest for persons already living in flood prone areas to have
an opportunity to purchase flood insurance and access to more adequate
limits of coverage to be indemnified for their losses in the event of
future flood disasters. To this end, FEMA established and carries out a
National Flood Insurance Program (NFIP), which enables interested
persons to purchase insurance against loss resulting from physical
damage to or loss of real or personal property arising from any flood
occurring in the United States. 42 U.S.C. 4011. In carrying out the
NFIP, FEMA operates a call center in conjunction with the FloodSmart
website (www.FloodSmart.gov). Together these methods of marketing and
outreach provide the mechanism for current and potential policyholders
to learn more about floods and flood insurance, contact an agent, or
assess their risk. The information collected from callers/visitors is
used to fulfill requests for published materials, email alerts, policy
rates, and agent contact information.
    Additionally, FEMA and the NFIP offer Agents.FloodSmart.gov as a
resource for agents. Upon website registration, agents can enroll in
the Agent Referral Program to receive free leads through the consumer
site or the call center as outlined above. This information collection
seeks approval to continue collecting name, address and telephone
number information from: (1) Business and residential property owners
and renters who voluntarily call to request flood insurance information
and possibly an insurance agent referral and, (2) insurance agents
interested in enrolling in the agent referral service.

Collection of Information

    Title: National Flood Insurance Program Call Center and Agent
Referral Enrollment Form.
    Type of Information Collection: Extension, without change, of a
currently approved information collection.
    OMB Number: 1660-0059.
    FEMA Forms: FEMA Form 517-0-1, National Flood Insurance Program
Agent Site Registration; FEMA Form

512-0-1, National Flood Insurance Program Agent Referral Questionnaire.
    Abstract: Consumer names, addresses, and telephone numbers
collected through the Call Center or FloodSmart website will be used
exclusively for providing information on flood insurance and/or
facilitate the purchase of a flood insurance policy through referrals
or direct transfers to insurance agents in the agent referral service.
Agent names, addresses, telephone numbers, and business information is
retained for dissemination to interested consumers who would like to
talk to an agent about purchasing a flood insurance policy as part of
the agent referral program.
    Affected Public: Individuals or households; Businesses or other
for-profit.
    Estimated Number of Respondents: 59,194.
    Estimated Number of Responses: 59,194.
    Estimated Total Annual Burden Hours: 2,819 hours.
    Estimated Total Annual Respondent Cost: $103,335.52.
    Estimated Respondents' Operation and Maintenance Costs: $0.
    Estimated Respondents' Capital and Start-Up Costs: $0.
    Estimated Total Annual Cost to the Federal Government: $406,941.

Comments

    Comments may be submitted as indicated in the ADDRESSES caption
above. Comments are solicited to (a) evaluate whether the proposed data
collection is necessary for the proper performance of the agency,
including whether the information shall have practical utility; (b)
evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (c) enhance the quality, utility, and
clarity of the information to be collected; and (d) minimize the burden
of the collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses.

William Holzerland,
Director, Information Management Division, Mission Support, Federal
Emergency Management Agency, Department of Homeland Security.
[FR Doc. 2018-21404 Filed 10-1-18; 8:45 am]
 BILLING CODE 9111-52-P


[Federal Register: March 16, 2009 (Volume 74, Number 49)]
[Notices]
[Page 11175-11176]
[DOCID:fr16mr09-118]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Pipeline and Hazardous Materials Safety Administration

Office of Hazardous Materials Safety: Notice of Application for
Special Permits

AGENCY: Pipeline and Hazardous Materials Safety Administration (PHMSA),
DOT.

ACTION: List of Applications for Special Permits.

-----------------------------------------------------------------------

SUMMARY: In accordance with the procedures governing the application
for, and the processing of, special permits from the Department of
Transportation's Hazardous Material Regulations (49 CFR Part 107,
Subpart B), notice is hereby given that the Office of Hazardous
Materials Safety has received the application described herein. Each
mode of transportation for which a particular special permit is
requested is indicated by a number in the ``Nature of Application''
portion of the table below as follows: 1--Motor vehicle, 2--Rail
freight, 3--Cargo vessel, 4--Cargo aircraft only, 5--Passenger-carrying
aircraft.

DATES: Comments must be received on or before April 15, 2009.
    Address Comments To: Record Center, Pipeline and Hazardous
Materials Safety Administration U.S. Department of Transportation,
Washington, DC 20590.
    Comments should refer to the application number and be submitted in
triplicate. If confirmation of receipt of comments is desired, include
a self-addressed stamped postcard showing the special permit number.

FOR FURTHER INFORMATION CONTACT: Copies of the applications are
available for inspection in the Records Center, East Building, PHH-30,
1200 New Jersey Avenue, Southeast, Washington DC or at http://
dms.dot.gov.
    This notice of receipt of applications for special permit is
published in accordance with Part 107 of the Federal hazardous
materials transportation law (49 U.S.C. 5117(b); 49 CFR 1.53(b)).

    Issued in Washington, DC, on March 06, 2009.
Delmer F. Billings,
Director, Office of Materials Hazardous, Special Permits and Approvals.

----------------------------------------------------------------------------------------------------------------
                                     Docket                           Regulation(s)         Nature of special
        Application number           number        Applicant             affected            permits thereof
----------------------------------------------------------------------------------------------------------------
                                               New Special Permits
----------------------------------------------------------------------------------------------------------------
14812-N..........................  .........  National             49 CFR 173.62        To authorize the
                                               Aeronautics and      Packing              transportation in
                                               Space                Instruction 134.     commerce of certain
                                               Administration                            Division 1.4C cartridge
                                               (NASA),                                   power devices which are
                                               Washington, DC.                           installed in a
                                                                                spacecraft and packaged
                                                                                in a non-DOT
                                                                                specification
                                                                                packaging. (mode 1).
14813-N..........................  .........  Organ Recovery       49 CFR 175.9(e)(5).  To authorize the
                                               Systems, Des                              transportation of the
                                               Plaines, IL.                              LifePort Kidney
                                                                                Transporter by air
                                                                                without being
                                                                                accompanied by a person
                                                                                qualified to operate
                                                                                it. (modes 4, 5).
14814-N..........................  .........  National             49 CFR 173.302a....  To authorize the
                                               Aeronautics and                           transportation in
                                               Space                                     commerce of certain
                                               Administration,                           Division 2.2 compressed
                                               Houston, TX (NASA).                       gases in non-DOT
                                                                                specification cylinders
                                                                                to support the
                                                                                International Space
                                                                                Station Human Research
                                                                                Facility Gas Delivery
                                                                                System. (modes 1, 2, 3,
                                                                                4, 5).
14817-N..........................  .........  Questar, Inc.,       49 CFR 173.12(b)(2)  To authorize the
                                               North Canton, OH.                         manufacture, marking,
                                                                                sale and use of a
                                                                                corrugated fiberboard
                                                                                box for use as the
                                                                                outer packaging for lab
                                                                                pack applications in
                                                                                accordance with 49 CFR
                                                                                173.12(b). (mode 1).
14818-N..........................  .........  Fleck Controls,      49 CFR 173.302a and  To authorize the
                                               LLC, Chardon, OH.    173.306(g).          transportation in
                                                                                commerce of non-DOT
                                                                                specification cylinders
                                                                                under the exception
                                                                                provided for water pump
                                                                                system tanks under in
                                                                                49 CFR 173.306(g).
                                                                                (modes 1, 2, 3).
----------------------------------------------------------------------------------------------------------------
                                               New Special Permits
----------------------------------------------------------------------------------------------------------------
14822-N..........................  .........  Oiltanking Joliet    49 CFR               To authorize personnel
                                               LLC, Channahon, IL.  177.834(i)(3).       to observe loading and
                                                                                unloading of cargo
                                                                                tanks by viewing video
                                                                                camera monitors in a
                                                                                control center instead
                                                                                of being physically
                                                                                located within 25 feet
                                                                                of the cargo tanks.
                                                                                (mode 1).
14823-N..........................  .........  FedEx Ground         49 CFR 172.202;      To authorize the return
                                               Package System,      172.203(c), (k),     shipment by motor
                                               Inc., Moon           (m); 172.301;        vehicle of hazardous
                                               Township, PA.        172.400;             materials that have
                                                                    172.302(c).          been accepted,
                                                                                transported, and
                                                                                subsequently determined
                                                                                to be non-compliant
                                                                                with the Hazardous
                                                                                Materials Regulations
                                                                                shipping paper, marking
                                                                                or labeling
                                                                                requirements. (mode 1).
----------------------------------------------------------------------------------------------------------------

 [FR Doc. E9-5506 Filed 3-13-09; 8:45 am]

BILLING CODE 4909-60-M


[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Page 2148]
[FR Doc No: 2022-00618]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Notice of Effectiveness of Exempt Wholesale Generator Status

------------------------------------------------------------------------
                                                     Docket Nos.
------------------------------------------------------------------------
Route 66 Solar Energy Center, LLC..........  EG22-1-000
Cypress Creek Fund 7 Tenant, LLC...........  EG22 EG22-2-000
Cypress Creek Fund 6 Tenant, LLC...........  EG22 EG22-3-000
Cypress Creek Fund 5 Tenant, LLC...........  EG22 EG22-4-000
CCP-PL Lessee, LLC.........................  EG22 EG22-5-000
Hecate Energy Highland LLC.................  EG22 EG22-6-000
EnerSmart Chula Vista BESS LLC.............  EG22 EG22-7-000
Sagebrush Line, LLC........................  EG22 EG22-8-000
PGR 2021 Lessee 2, LLC.....................  EG22 EG22-9-000
Beulah Solar, LLC..........................  EG22 EG22-10-000
Ellis Solar, LLC...........................  EG22 EG22-11-000
King Creek Wind Farm 1 LLC.................  EG22 EG22-12-000
King Creek Wind Farm 2 LLC.................  EG22 EG22-13-000
Calhoun Solar Energy LLC...................  EG22 EG22-14-000
ENGIE 2020 ProjectCo-NH1 LLC...............  EG22 EG22-15-000
Dunns Bridge Solar Center, LLC.............  EG22 EG22-16-000
Jackson Generation, LLC....................  EG22 EG22-17-000
MPH AL Pierce, LLC.........................  EG22 EG22-18-000
------------------------------------------------------------------------

    Take notice that during the month of December 2021, the status of
the above-captioned entities as Exempt Wholesale Generators became
effective by operation of the Commission's regulations. 18 CFR
366.7(a)(2021).

    Dated: January 7, 2022.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2022-00618 Filed 1-12-22; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11300-11301]
[FR Doc No: 2021-03729]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-7012]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Use of Public Human
Genetic Variant Databases To Support Clinical Validity for Genetic and
Genomic-Based In Vitro Diagnostics

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995.

DATES: Submit written comments (including recommendations) on the
collection of information by March 26, 2021.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-0850. Also include the FDA docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Agency Information Collection Activities; Proposed Collection; Comment
Request; Use of Public Human Genetic Variant Databases To Support
Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics

OMB Control Number 0910-0850--Extension

    Section 2011 of the 21st Century Cures Act of 2016 (Pub. L. 114-
255) encourages the FDA to develop new approaches for addressing
regulatory science issues as part of the Precision Medicine Initiative
(PMI).
    In the Federal Register of April 13, 2018 (83 FR 16110), FDA
announced the availability of a guidance for industry entitled ``Use of
Public Human Genetic Variant Databases to Support Clinical Validity for
Genetic and Genomic-Based In Vitro Diagnostics; Guidance for
Stakeholders and Food and Drug Administration Staff.'' \1\ The guidance
describes one part of FDA's PMI effort to create a flexible and
adaptive regulatory approach to the oversight of next generation
sequencing (NGS)-based tests. The goal of this effort is to help ensure
patients receive accurate and meaningful test results, while promoting
innovation in test development. The guidance describes how publicly
accessible databases of human genetic variants can serve as sources of
valid scientific evidence to support the clinical validity of genotype-
phenotype relationships in FDA's regulatory review of both NGS-based
tests and genetic and genomic tests based on other technologies.
Publicly accessible genetic databases may be useful to support the
clinical validity of NGS tests as well as single gene or panel tests
that use other technology.
---------------------------------------------------------------------------

    \1\ Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-public-human-genetic-variant-databases-support-clinical-validity-genetic-and-genomic-based-vitro.
---------------------------------------------------------------------------

    The guidance describes FDA's considerations in determining whether
a genetic variant database is a source of valid scientific evidence
that could support the clinical validity of an NGS-based test. The
guidance further outlines the process by which administrators \2\ of
genetic variant databases could voluntarily apply to FDA for
recognition, and how FDA would review such applications and
periodically reevaluate recognized databases. The guidance also
recommends that, at the time of recognition, the database administrator
make information regarding policies, procedures, and conflicts of
interest publicly available and accessible on the genetic variant
database's website.
---------------------------------------------------------------------------

    \2\ FDA acknowledges that many databases may not use the term
``administrator'' or may have a committee of individuals that
oversee the database. Therefore, for the purpose of this guidance, a
genetic variant database administrator is the entity or entities
that oversee database operations.
---------------------------------------------------------------------------

    Respondents are administrators of genetic databases. Our estimate
of five respondents per year is based on the current number of
databases that may meet FDA recommendations for recognition and seek
such recognition.
    Based on our experience and the nature of the information, we
estimate that it will take an average of 80 hours to complete and
submit an application for recognition. We estimate that maintenance of
recognition activities will take approximately one-fourth of that time
(20 hours) annually. We estimate that it will take approximately 1 hour
to post the information on the website.
    In the Federal Register of September 23, 2020 (85 FR 59801), we
published a 60-day notice requesting public comment on the proposed
collection of information. FDA received two comments. One comment was
not relevant to the topic or information collection. A summary of the
other comment and our response are as follows:
    (Comment) One comment expressed concerns and suggestions regarding
the collection, storage, and security of personally identifiable
information (PII) and protected health information (PHI).
    (Response) The guidance document ``Use of Public Human Genetic
Variant Databases to Support Clinical Validity for Genetic and Genomic-
Based In Vitro Diagnostics'' describes, among other things, FDA's
considerations in determining whether a publicly accessible genetic
variant database is a source of valid scientific evidence that could
support the clinical validity of genetic and genomic-based tests in a
premarket submission and outlines the process by which administrators
of publicly accessible genetic variant databases could voluntarily
apply to FDA for recognition, and how FDA would assess such
applications and periodically reevaluate recognized databases. FDA
recommends that genetic database administrators should identify the
applicable laws and regulations to assure that any requirements are
addressed and transparently documented. Genetic variant database
administrators should also put in place adequate security measures to
ensure the protection and privacy of PII and PHI and provide

training for database staff on security and privacy protection. The
guidance recommends that, among other considerations, such a genetic
variant database would collect, store, and report data and conclusions
in compliance with all applicable requirements regarding protected
health information, patient privacy, research subject protections, and
data security. In section V.A of the guidance, FDA discusses security
and privacy of such data, stating that ``[g]enetic variant database
operations must be in compliance with all applicable federal laws and
regulations (e.g., the Health Insurance Portability and Accountability
Act, the Genetic Information Nondiscrimination Act, the Privacy Act,
the Federal Policy for the Protection of Human Subjects (``Common
Rule''), etc.) regarding protected health information, patient privacy,
research involving human subjects, and data security, as applicable.''
    However, we believe the comment may misunderstand the subject of
the information collection request. We are requesting extension of the
OMB approval of the information collection associated with the guidance
document, i.e., the application for recognition of a publicly
accessible genetic variant database as a source of valid scientific
evidence that could support the clinical validity of genetic and
genomic-based tests in a premarket submission, as well as record
maintenance and public disclosure related to such recognition. The
application for recognition does not include submission of PII or PHI
that may be contained in a genetic variant database. Rather, the
application includes standard operating procedures and other documents
related to the database's handling of PII and PHI confidentiality and
privacy, among other considerations. The information collected in the
application for recognition is used to evaluate the database's
oversight and governance procedures to determine that, among other
things, they are designed to ensure the protection of PII and PHI and
provide appropriate training for database staff.
    We have not revised the information collection based on the
comment.
    FDA estimates the burden of this collection of information as
follows:

                                                      Table 1--Estimated Annual Reporting Burden 1
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of
                              Activity                                  Number of      responses per     Total annual    Average burden    Total hours
                                                                       respondents       respondent       responses       per response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Application for recognition of genetic database....................               5                1                5               80              400
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

                                                    Table 2--Estimated Annual Recordkeeping Burden 1
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of                       Average burden
                              Activity                                  Number of       records per      Total annual         per          Total hours
                                                                      recordkeepers     recordkeeper       records       recordkeeping
--------------------------------------------------------------------------------------------------------------------------------------------------------
Maintenance of recognition activities..............................               5                1                5               20              100
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

                                                Table 3--Estimated Annual Third-Party Disclosure Burden 1
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of
                              Activity                                  Number of     disclosures per    Total annual    Average burden    Total hours
                                                                       respondents       respondent      disclosures     per disclosure
--------------------------------------------------------------------------------------------------------------------------------------------------------
Public disclosure of policies, procedures, and conflicts of                       5                1                5                1                5
 interest..........................................................
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Based on a review of the information collection since our last
request for OMB approval, we have made no adjustments to our burden
estimate.

    Dated: February 16, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-03729 Filed 2-23-21; 8:45 am]
BILLING CODE 4164-01-P